Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Ramps Up Innovation, Logistics to Power Growth
Massimo (NASDAQ: MAMO) is making strategic moves to actively enhance its position in the powersports and…
-
QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Unveils Significant Resource Estimate at Storm Copper Project
Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a mineral exploration company focused on high-grade metals deposits,…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands Portfolio with Additional Solar Project in Upstate New York
SolarBank is developing a 4.584 MW DC ground-mount solar project in upstate New York, projected…